Treatment of accidental extravasation of anthracyclines
AssigneeAntianthra APS
InventorsSeppo W. Langer, Peter B. Jensen, Maxwell Sehested
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for pharmacological treatment of accidental extravasation of topoisomerase II poisons, such as anthracyclines. In particular, the invention relates to the use of a topo II catalytic inhibitor, such as the bisdioxopiperazine ICRF-187, for the treatment of an accidental extravasation of a topoisomerase II poison. A method for treatment of such extravasation of a topoisomerase poison such as the anthracyclines, daunorubicin, doxorubicin, epirubicin, or idarubicin is disclosed.
Claims31
A method for preventing or treating local tissue damage due to accidental extravasation of a cytotoxic topoisomerase II poison in a patient receiving treatment with the topoisomerase II poison, comprising administration of a topo II catalytic inhibitor to the patient in need thereof,
- where said topo II catalytic inhibitor is a bisdioxopiperazine.
Dependencies are inferred from the claim text.